Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Sci Rep ; 10(1): 6800, 2020 04 22.
Article in English | MEDLINE | ID: mdl-32322005

ABSTRACT

Diabetes is associated with cognitive impairment and greater risk for dementia, but the role of gamma-glutamyltransferase (γ-GT) in dementia has not been elucidated. We determined incident dementia including Alzheimer's disease and vascular dementia, analyzing data from participants aged 40 years or older in the National Health Insurance Database, collected by the National Health Insurance Service in Korea, from January 2009 to December 2015. During a median follow-up of 7.6 years, 272,657 participants were diagnosed as having dementia. Higher serum γ-GT was associated with increased risk of dementia (HR = 1.22, 95% CI = 1.20-1.24), and had a strong positive association with early onset dementia (HR = 1.32, 95% CI = 1.24-1.40). An additive impact of higher γ-GT on dementia was observed regardless of glycemic status, and prevalent diabetes with the highest γ-GT quartile had a 1.8-fold increased dementia risk (HR = 1.82, 95% CI = 1.78-1.85). This effect of γ-GT concentration in diabetes was more prominent in individuals with vascular dementia (HR = 1.94, 95% CI = 1.84-2.04). In subgroup analysis, young age, male sex, and relatively healthy subjects with a higher γ-GT quartile had more increased dementia risk. In conclusion, γ-GT concentration as well as glycemic status could be a future risk factor for dementia in the general population.


Subject(s)
Dementia/epidemiology , Diabetes Mellitus/epidemiology , Prediabetic State/epidemiology , gamma-Glutamyltransferase/blood , Aged , Alzheimer Disease/epidemiology , Alzheimer Disease/ethnology , Cohort Studies , Comorbidity , Dementia/ethnology , Dementia, Vascular/epidemiology , Dementia, Vascular/ethnology , Diabetes Mellitus/ethnology , Female , Humans , Incidence , Longitudinal Studies , Male , Middle Aged , National Health Programs/statistics & numerical data , Prediabetic State/ethnology , Prevalence , Republic of Korea/epidemiology , Risk Factors
2.
Medicine (Baltimore) ; 96(26): e7165, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28658107

ABSTRACT

Renal hyperfiltration is closely linked to cardiometabolic disorders, and it may increase the mortality risk of the general population. Despite the well-established association between cardiometabolic diseases and sarcopenia, the relationship between renal hyperfiltration and sarcopenia has not yet been assessed.This population-based, cross-sectional study used a nationally representative sample of 13,800 adults from the 2008 to 2011 Korea National Health and Nutrition Examination Survey. Renal hyperfiltration was defined as the age- and sex-specific glomerular filtration rate above the 90th percentile in subjects with normal kidney function (>60 mL/min/1.73 m). Appendicular skeletal muscle (ASM), measured by dual-energy x-ray absorptiometry, was used to assess pre-sarcopenia, which the international consensus defines as both ASM per se and ASM that was adjusted for the body mass index and the height.A total of 1402 (10.2%) participants were classified as having renal hyperfiltration. The prevalence of pre-sarcopenia ranged from 11.6% to 33.0%, by definition. Individuals with pre-sarcopenia had higher risks of renal hyperfiltration compared to those without pre-sarcopenia (10.9% vs 17.4%, P < .001; odds ratio [OR] = 1.71, 95% confidential interval [CI] = 1.48-1.99, P < .001). Multiple logistic regression analyses also demonstrated this independent association between pre-sarcopenia and renal hyperfiltration, following adjustment for confounding factors such as insulin resistance and obesity (OR = 1.84, 95% CI = 1.57-2.15, P < .001).In the general population of healthy individuals, pre-sarcopenia might be associated with renal hyperfiltration independent of obesity or insulin resistance.


Subject(s)
Insulin Resistance , Kidney Diseases/physiopathology , Muscle, Skeletal/diagnostic imaging , Obesity/physiopathology , Sarcopenia/physiopathology , Absorptiometry, Photon , Adult , Aged , Cross-Sectional Studies , Databases, Factual , Female , Glomerular Filtration Rate , Humans , Kidney Diseases/diagnostic imaging , Kidney Diseases/epidemiology , Male , Middle Aged , National Health Programs , Obesity/diagnostic imaging , Obesity/epidemiology , Prevalence , Prodromal Symptoms , Republic of Korea , Risk Factors , Sarcopenia/diagnostic imaging , Sarcopenia/epidemiology , Young Adult
3.
PLoS One ; 11(5): e0154683, 2016.
Article in English | MEDLINE | ID: mdl-27135947

ABSTRACT

Beneficial effects of omega-3 fatty acid (O3FA) supplementation in a wide range of disease condition have been well studied. However, there is limited information regarding the effects of O3FAs on chronic kidney disease (CKD), especially in diabetic nephropathy (DN) with hypertriglyceridemia. We investigate whether O3FA supplementation could help maintain renal function in patients with diabetes and hypertriglyceridemia. Total 344 type 2 diabetic patients with a history of O3FA supplementation for managing hypertriglyceridemia were included. Reduction in urine albumin to creatinine ratio (ACR) and glomerular filtrate rate (GFR) were examined. Subgroup analyses were stratified according to the daily O3FA doses. Serum total cholesterol, triglyceride, and urine ACR significantly reduced after O3FA supplementation. Overall, 172 (50.0%) patients did not experience renal function loss, and 125 (36.3%) patients had a GFR with a positive slope. The patients treated with O3FAs at 4g/day showed greater maintenance in renal function than those treated with lower dosages (p < 0.001). This dose dependent effect remains significant after adjustment for multiple variables. O3FA supplementation in diabetic patients with hypertriglyceridemia shows benefits of reducing albuminuria and maintaining renal function. The effects are dependent on the dose of daily O3FA supplementation.


Subject(s)
Diabetes Mellitus/drug therapy , Diabetic Nephropathies/drug therapy , Fatty Acids, Omega-3/therapeutic use , Hypertriglyceridemia/drug therapy , Aged , Albuminuria/drug therapy , Disease Progression , Female , Glomerular Filtration Rate/physiology , Humans , Logistic Models , Male , Middle Aged , Retrospective Studies
4.
Metabolism ; 63(11): 1455-61, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25200186

ABSTRACT

OBJECTIVE: Estrogen plays an important role in the control of energy balance in the hypothalamus. Leptin-independent STAT3 activation (i.e., tyrosine(705)-phosphorylation of STAT3, pSTAT3) in the hypothalamus is hypothesized as the primary mechanism of the estrogen-induced anorexic response. However, the type of estrogen receptor that mediates this regulation is unknown. We investigated the role of the G protein-coupled receptor 30 (GPR30) in estradiol (E2)-induced STAT3 activation in the hypothalamus. MATERIALS/METHODS: Regulation of STAT3 activation by E2, G-1, a specific agonist of GPR30 and G-15, a specific antagonist of GPR30 was analyzed in vitro and in vivo. Effect of GPR30 activation on eating behavior was analyzed in vivo. RESULTS: E2 stimulated pSTAT3 in cells expressing GPR30, but not expressing estrogen receptor ERα and ERß. G-1 induced pSTAT3, and G-15 inhibited E2-induced pSTAT3 in primary cultures of hypothalamic neurons. A cerebroventricular injection of G-1 increased pSTAT3 in the arcuate nucleus of mice, which was associated with a decrease in food intake and body weight gain. CONCLUSIONS: These results suggest that GPR30 is the estrogen receptor that mediates the anorectic effect of estrogen through the STAT3 pathway in the hypothalamus.


Subject(s)
Anorexia/physiopathology , Estrogens/physiology , Hypothalamus/physiopathology , Receptors, Estrogen/physiology , Receptors, G-Protein-Coupled/physiology , STAT3 Transcription Factor/metabolism , Signal Transduction/physiology , Animals , Base Sequence , DNA Primers , HeLa Cells , Humans , Mice , Reverse Transcriptase Polymerase Chain Reaction
5.
J Am Heart Assoc ; 3(1): e000650, 2014 Feb 26.
Article in English | MEDLINE | ID: mdl-24572249

ABSTRACT

BACKGROUND: The mortality rate from cardiovascular disease (CVD) among young adults has declined less than that in the older population, raising concerns about the increasing prevalence of obesity-related conditions including hypercholesterolemia in the younger population. We investigated the age-standardized mean levels of serum cholesterols and the prevalence, awareness, treatment and control rates of hyper-low-density lipoprotein (LDL)-cholesterolemia based on age. METHODS AND RESULTS: Nationally representative samples of 19 489 subjects aged ≥20 years were analyzed from the Korea National Health and Nutrition Examination Surveys 2008-2010. Hyper-LDL-cholesterolemia was individually evaluated by the 2004 National Cholesterol Education Program Adult Treatment Panel III guidelines. Age-standardized mean levels of total cholesterol, high-density lipoprotein-cholesterol, LDL-cholesterol, and triglycerides were 186.8, 48.0, 112.9, and 136.0 mg/dL, respectively. Age-standardized prevalence of hyper-LDL-cholesterolemia was 23.2% (men, 25.5%; women, 21.8%). Among subjects with hyper-LDL-cholesterolemia, awareness and treatment rates were significantly lower in younger adults (<50 years) compared to older adults ≥50 years (awareness, 8.0% versus 21.5%; treatment, 5.1% versus 18.5%, all Ps<0.001), indicating significant discrepancies in awareness and treatment rates of hypercholesterolemia between younger and older adults. Among subjects aware of their hyper-LDL-cholesterolemia, younger adults were more likely to have controlled LDL-cholesterol than the elderly (82.1% versus 67.5%, P<0.001). CONCLUSIONS: Compared to the elderly, significant proportions of young and middle-aged adults are unaware of their hypercholesterolemia and are not treated with proper lipid-lowering medications. Early screening, education, and proper management should be stressed in national public healthcare policies to reduce the increasing burden of CVD in the younger population with undiagnosed hypercholesterolemia.


Subject(s)
Anticholesteremic Agents/therapeutic use , Awareness , Cholesterol, LDL/blood , Health Knowledge, Attitudes, Practice , Hypercholesterolemia , Adult , Age Distribution , Age Factors , Aged , Biomarkers/blood , Cross-Sectional Studies , Female , Health Behavior , Health Surveys , Humans , Hypercholesterolemia/blood , Hypercholesterolemia/diagnosis , Hypercholesterolemia/drug therapy , Hypercholesterolemia/epidemiology , Male , Middle Aged , Nutrition Surveys , Prevalence , Republic of Korea/epidemiology , Risk Factors , Time Factors , Treatment Outcome , Triglycerides/blood , Young Adult
6.
Phytother Res ; 26(1): 142-7, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22034219

ABSTRACT

Many studies have documented that ginseng has antidiabetic and antiobesity effects, but the mechanism of the effects has not been elucidated. The aim of this study was to determine the effect of Korean red ginseng (KRG, Panax ginseng) and investigate the mechanism of antidiabetic and antiobesity effects in obese insulin resistant animal models. Sprague-Dawley (SD) rats were divided into three groups: a control group (group I) fed a normal diet, another group (group II) fed only high fat diet (HFD) and a third group (group III) fed HFD with KRG (200 mg/kg, oral) for 18 weeks. The body weight, food intake, adipose tissues, liver, kidney, pancreas, adiponectin, and leptin were measured. Blood glucose, insulin tolerance test, and hyperinsulinemic euglycemic clamp test were investigated. A significant weight reduction, especially fat mass reduction, was observed in the KRG treated group. Increased insulin sensitivity was found in the KRG treated group. We observed increased insulin signalling, increased phosphorylation of IR, IRS-1, Akt, and membranous GLUT4 in muscle by Western blotting assay. In conclusion, KRG may have antidiabetic and antiobesity effects due to partly increased insulin sensitivity by increased adipokine and partly enhanced insulin signalling.


Subject(s)
Adipose Tissue/drug effects , Anti-Obesity Agents/therapeutic use , Diet, High-Fat/adverse effects , Hypoglycemic Agents/therapeutic use , Insulin Resistance , Panax , Phytotherapy , Adipokines/metabolism , Adipose Tissue/metabolism , Animals , Anti-Obesity Agents/pharmacology , Blotting, Western , Dietary Fats/adverse effects , Disease Models, Animal , Glucose Transporter Type 4/metabolism , Hypoglycemic Agents/pharmacology , Insulin Receptor Substrate Proteins/metabolism , Male , Muscle, Skeletal/metabolism , Phosphorylation , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rats , Rats, Sprague-Dawley , Receptor, Insulin/metabolism , Signal Transduction/drug effects , Weight Loss/drug effects
7.
Lipids ; 45(12): 1109-16, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20960069

ABSTRACT

Saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) show different effects on the development of insulin resistance. In this study, we compared the effect of dietary SFA and MUFA on the insulin signaling pathway in the skeletal muscle of a type 2 diabetic animal model. Twenty-nine-week-old male Otsuka Long-Evans Tokushima fatty (OLETF) rats were randomly divided into three groups and fed one of the following diets for 3 weeks; a normal chow diet, an SFA (lard oil) enriched or a MUFA (olive oil) enriched high-fat diet. The vastus lateralis muscle was used for analyses. Insulin tolerance test showed improved insulin sensitivity in rats fed the MUFA diet, as compared to those fed the SFA diet (p < 0.001). The SFA diet reduced IRS-1 expression and phosphorylated PI3K levels in skeletal muscle, as compared with a chow diet (p < 0.001, respectively). On the contrary, muscle IRS-2 expression and phosphorylated ERK1/2 was significantly increased in rats fed the SFA diet (p < 0.001, respectively). Membrane translocation of glucose transporter type 4 decreased in the skeletal muscle of rats fed the SFA diet, as compared to those fed a chow diet (p < 0.001). These changes in insulin signaling pathway in skeletal muscle were not observed in rats fed the MUFA diet. In conclusion, the beneficial effect of dietary MUFA on insulin sensitivity is associated with a conserved IRS-1/PI3K insulin signaling pathway which was altered by dietary SFA.


Subject(s)
Fatty Acids, Monounsaturated/metabolism , Fatty Acids/metabolism , Insulin Receptor Substrate Proteins/metabolism , Insulin/metabolism , Muscle, Skeletal/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction , Animals , Dietary Fats, Unsaturated , Fatty Acids/pharmacology , Fatty Acids, Monounsaturated/pharmacology , Glucose Transporter Type 4/metabolism , Insulin Resistance , Male , Muscle, Skeletal/chemistry , Muscle, Skeletal/enzymology , Rats , Rats, Inbred OLETF
8.
Cardiovasc Res ; 87(4): 713-22, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20299332

ABSTRACT

AIMS: We have investigated the effects of magnesium lithospermate B (MLB), the active compound of the Oriental herbal remedy, Salvia miltiorrhizae, on endothelial dysfunction associated with diabetes mellitus using cultured endothelial cells and an animal model of type 2 diabetes mellitus. METHODS AND RESULTS: The effect of MLB on vasodilatory function in Otsuka Long-Evans Tokushima Fatty (OLETF) rats was assessed. MLB treatment for 20 weeks starting at 12 weeks attenuated the decrease in endothelium-dependent vasodilation in OLETF rats. MLB treatment also increased serum nitrite level and reduced serum advanced glycation end products concentration. The effect of MLB was greater than an equivalent dose of alpha-lipoic acid (alphaLA), a popular antioxidant treatment. MLB rescued the inhibition of endothelial nitric oxide synthase (eNOS) activity and eNOS phosphorylation in endothelial cells cultured in hyperglycaemia. This effect was dependent on Akt phosphorylation and associated with decreased O-linked N-acetylglucosamine protein modification of eNOS. MLB also increased nuclear factor erythroid 2-related factor-2 (Nrf-2) activation in a phosphoinositide 3-kinase/Akt pathway dependent manner. MLB treatment induced the expression of the Nrf-2-regulated antioxidant enzyme, heme oxygenase-1. The antioxidant alphaLA could not produce this effect. Moreover, MLB decreased oxidative stress and endothelial cell apoptosis caused by hyperglycaemia. CONCLUSION: MLB is a naturally occurring, new generation antioxidant that activates eNOS and ameliorates endothelial dysfunction in diabetes by enhancing vasodilation in addition to reducing oxidative stress. The relative strong performance of MLB makes it an ideal candidate for further, expanded trials as a new generation of antioxidant to treat diabetes-related complications.


Subject(s)
Antioxidants/pharmacology , Diabetes Mellitus, Type 2/drug therapy , Diabetic Angiopathies/drug therapy , Drugs, Chinese Herbal/pharmacology , Endothelium, Vascular/drug effects , Glucose/metabolism , Vasodilation/drug effects , Animals , Apoptosis/drug effects , Cell Adhesion/drug effects , Cells, Cultured , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/physiopathology , Diabetic Angiopathies/etiology , Diabetic Angiopathies/metabolism , Diabetic Angiopathies/physiopathology , Disease Models, Animal , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Endothelium, Vascular/physiopathology , Glycation End Products, Advanced/blood , Glycosylation , Heme Oxygenase-1/metabolism , Humans , Leukocytes/drug effects , NF-E2-Related Factor 2/metabolism , Nitric Oxide Synthase Type III/metabolism , Nitrites/blood , Oxidative Stress/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Protein Processing, Post-Translational , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Inbred OLETF , Rats, Long-Evans , Reactive Oxygen Species/metabolism , Time Factors
9.
Atherosclerosis ; 211(1): 69-76, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20172524

ABSTRACT

Hyperglycemia-induced oxidative stress is known to play an important role in the development of several diabetic complications, including atherosclerosis. Although a number of antioxidants are available, none have been found to be suitable for regulating the oxidative stress response and enhancing antioxidative defense mechanisms. In this study, we evaluated the effects of magnesium lithospermate B (LAB) against oxidative stress. We also endeavored to identify the target molecule of LAB in vascular smooth muscle cells (VSMCs) and the underlying biochemical pathways related to diabetic atherosclerosis. Modified MTT and transwell assays showed that the increased proliferation and migration of rat aortic VSMCs in culture with high glucose was significantly inhibited by LAB. LAB also attenuated neointimal hyperplasia after balloon catheter injury in diabetic rat carotid arteries. To determine molecular targets of LAB, we studied the effects of LAB on aldose reductase (AR) activity, O-GlcNAcylation, and protein kinase C (PKC) activity in VSMCs under normoglycemic or hyperglycemic conditions and showed the improvement of major biochemical pathways by LAB. Potential involvement of the nuclear factor erythroid 2-related factor-2 (Nrf2)--antioxidant responsive element (ARE)-NAD(P)H: quinone oxidoreductase-1 (NQO1) pathway was assessed using siRNA methods. We found that LAB activates the NQO1 via the Nrf2-ARE pathway, which plays an important role in inhibition of the major molecular mechanisms that lead to vascular damage and the proliferation and migration of VSMCs. Together, these findings demonstrate that the induction of the Nrf2-ARE-NQO1 pathway by LAB could be a new therapeutic strategy to prevent diabetic atherosclerosis.


Subject(s)
Atherosclerosis/prevention & control , Drugs, Chinese Herbal/therapeutic use , NAD(P)H Dehydrogenase (Quinone)/physiology , NF-E2-Related Factor 2/physiology , Response Elements/physiology , Aldehyde Reductase/metabolism , Animals , Antioxidants/pharmacology , Atherosclerosis/metabolism , Diabetes Mellitus, Experimental/complications , Male , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Oxidative Stress/drug effects , Protein Kinase C/metabolism , Rats , Rats, Sprague-Dawley
10.
Metabolism ; 58(8): 1170-7, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19477471

ABSTRACT

Ginseng has been reported to ameliorate hyperglycemia in experimental and clinical studies; however, its mechanism of action remains unclear. In this study, we investigated the metabolic effects and putative molecular mechanisms of Korean red ginseng (KRG, Panax ginseng) in animal models for type 2 diabetes mellitus (T2DM) and peripheral insulin-responsive cell lines. Korean red ginseng was administered orally at a dose of 200 mg/(kg d) to Otsuka Long-Evans Tokushima fatty rats for 40 weeks. Initially, chronic administration of KRG reduced weight gain and visceral fat mass in the early period without altering food intake. The KRG-treated Otsuka Long-Evans Tokushima fatty rats showed improved insulin sensitivity and significantly preserved glucose tolerance compared with untreated control animals up to 50 weeks of age, implying that KRG attenuated the development of overt diabetes. KRG promoted fatty acid oxidation by the activation of adenosine monophosphate-activated protein kinase (AMPK) and phosphorylation of acetyl-coenzyme A carboxylase in skeletal muscle and cultured C2C12 muscle cells. Increased expression of peroxisome proliferator-activated receptor-gamma coactivator-1alpha, nuclear respiratory factor-1, cytochrome c, cytochrome c oxidase-4, and glucose transporter 4 by KRG treatment indicates that activated AMPK also enhanced mitochondrial biogenesis and glucose utilization in skeletal muscle. Although these findings suggest that KRG is likely to have beneficial effects on the amelioration of insulin resistance and the prevention of T2DM through the activation of AMPK, further clinical studies are required to evaluate the use of KRG as a supplementary agent for T2DM.


Subject(s)
Diabetes Mellitus, Type 2/prevention & control , Hypoglycemic Agents/pharmacology , Insulin Resistance , Insulin/metabolism , Intra-Abdominal Fat/drug effects , Obesity/metabolism , Panax , Plant Preparations/pharmacology , Animals , Blotting, Western , Glucose Tolerance Test , Glucose Transporter Type 4/drug effects , Glucose Transporter Type 4/metabolism , Hypoglycemic Agents/administration & dosage , Male , Obesity/complications , Obesity/physiopathology , Plant Preparations/administration & dosage , Rats , Rats, Inbred OLETF
11.
Eur J Pharmacol ; 586(1-3): 226-33, 2008 May 31.
Article in English | MEDLINE | ID: mdl-18387604

ABSTRACT

Vascular smooth muscle cell (VSMC) proliferation and migration in response to platelet-derived growth factor (PDGF) play an important role in the development of atherosclerosis and restenosis. Recent evidence indicates that PDGF increases intracellular levels of reactive oxygen species in VSMCs and that both PDGF-induced VSMC proliferation and migration are reactive oxygen species-dependent. Danshen is a representative oriental medicine used for the treatment of vascular disease. Previously, we reported that magnesium lithospermate B, an active component of Danshen, is a potent antioxidant. Thus we investigated the therapeutic potential of magnesium lithospermate B in neointimal formation after carotid artery injury in rats along with its effects on the PDGF signaling pathway for stimulating VSMC proliferation and migration in vitro. PDGF is dimeric glycoprotein composed of two A or two B chains. In this study, we used PDGF-BB, which is one of the isoforms of PDGF (i.e., PDGF-AA, PDGF-BB, and PDGF-AB). Our results demonstrated that magnesium lithospermate B directly scavenged reactive oxygen species in a xanthine/xanthine oxidase system and reduced PDGF-BB-induced intracellular reactive oxygen species generation in VSMCs. In a rat carotid artery balloon injury model, magnesium lithospermate B treatment (10 mg/kg/day, i.p) showed a significant effect on the prevention of neointimal formation compared with vehicle treatment. In cultured VSMCs, magnesium lithospermate B significantly attenuated PDGF-BB-induced cell proliferation and migration as measured by 3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2-tetrazolium bromide (MTT) assay and transwell migration assays, respectively. Further, magnesium lithospermate B inhibited PDGF-BB-induced phosphorylation of phospatidylinositol 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathways by scavenging reactive oxygen species. Together, these data indicated that magnesium lithospermate B, a potent reactive oxygen species scavenger, prevented both injury-induced neointimal formation in vivo and PDGF-BB-induced VSMC proliferation and migration in vitro, suggesting that magnesium lithospermate B may be a promising agent to prevent atherosclerosis and restenosis following angioplasty.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Antioxidants/therapeutic use , Carotid Artery Injuries/drug therapy , Carotid Artery Injuries/pathology , Drugs, Chinese Herbal/therapeutic use , Free Radical Scavengers/therapeutic use , Neovascularization, Pathologic/drug therapy , Animals , Aorta, Thoracic/cytology , Aorta, Thoracic/drug effects , Blotting, Western , Catheterization , Cell Movement/drug effects , Cell Proliferation/drug effects , Cell Separation , Drugs, Chinese Herbal/isolation & purification , Electrophoresis, Polyacrylamide Gel , Immunohistochemistry , Male , Myocytes, Smooth Muscle/drug effects , Plant Roots/chemistry , Platelet-Derived Growth Factor/antagonists & inhibitors , Platelet-Derived Growth Factor/pharmacology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Salvia miltiorrhiza/chemistry , Signal Transduction/drug effects
12.
Curr Med Chem ; 13(10): 1203-18, 2006.
Article in English | MEDLINE | ID: mdl-16719780

ABSTRACT

Currently available therapeutic options for non-insulin-dependent diabetes mellitus, such as dietary modification, oral hypoglycemics, and insulin, have limitations of their own. Many natural products and herbal medicines have been recommended for the treatment of diabetes. The present paper reviews medicinal plants that have shown experimental or clinical antidiabetic activity and that have been used in traditional systems of medicine; the review also covers natural products (active natural components and crude extracts) isolated from the medicinal plants and reported during 2001 to 2005. Many kinds of natural products, such as terpenoids, alkaloids, flavonoids, phenolics, and some others, have shown antidiabetic potential. Particularly, schulzeines A, B, and C, radicamines A and B, 2,5-imino-1,2,5-trideoxy-L-glucitol, beta-homofuconojirimycin, myrciacitrin IV, dehydrotrametenolic acid, corosolic acid (Glucosol), 4-(alpha-rhamnopyranosyl)ellagic acid, and 1,2,3,4,6-pentagalloylglucose have shown significant antidiabetic activities. Among active medicinal herbs, Momordica charantia L. (Cucurbitaceae), Pterocarpus marsupium Roxb. (Leguminoceae), and Trigonella foenum graecum L. (Leguminosae) have been reported as beneficial for treatment of type 2 diabetes.


Subject(s)
Hypoglycemic Agents/chemistry , Hypoglycemic Agents/therapeutic use , Plants, Medicinal/chemistry , Alkaloids/chemistry , Alkaloids/therapeutic use , Animals , Diabetes Mellitus/drug therapy , Flavonoids/chemistry , Flavonoids/therapeutic use , Humans , Hypoglycemic Agents/isolation & purification , Phytotherapy
SELECTION OF CITATIONS
SEARCH DETAIL